Citius Oncology (CTOR) Work In Process (2024 - 2026)

Citius Oncology (CTOR) has reported Work In Process for 3 consecutive years, with $7.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Work In Process changed N/A year-over-year to $7.0 million in Q2 2026; TTM through Jun 2026 was $7.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $11.7 million, up 448.71% from the prior year.
• Work In Process was $7.0 million for Q2 2026 at Citius Oncology, roughly flat from $7.0 million in the prior quarter.
• Over five years, Work In Process peaked at $11.7 million in Q3 2025 and troughed at $2.1 million in Q3 2024.
• A 3-year average of $6.9 million and a median of $7.0 million in 2025 frame the typical range for Work In Process.
• The widest YoY moves for Work In Process: up 448.71% in 2025, down 448.71% in 2025.
• Over 3 years, Work In Process stood at $2.1 million in 2024, then jumped by 225.79% to $7.0 million in 2025, then changed by 0.0% to $7.0 million in 2026.
• The last three Work In Process figures came in at $7.0 million (Q2 2026), $7.0 million (Q1 2026), and $7.0 million (Q4 2025), per Business Quant data.